Empreendimentos Pague Menos S.A. (BVMF:PGMN3)
Brazil · Delayed Price · Currency is BRL 3.910
-0.020 (-0.51%)
Aug 7, 2025, 5:07 PM GMT-3
Regulus Therapeutics Market Cap
BVMF:PGMN3 has a market cap or net worth of 2.42 billion as of August 7, 2025. Its market cap has increased by 49.67% in one year.
Market Cap
2.42B
Enterprise Value
5.88B
Revenue
13.68B
Ranking
n/a
PE Ratio
40.64
Stock Price
$3.91
Market Cap Chart
Since September 2, 2020, BVMF:PGMN3's market cap has decreased from 4.44B to 2.42B, a decrease of -45.47%. That is a compound annual growth rate of -11.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 2.43B | 33.82% |
| Dec 30, 2024 | 1.82B | -15.12% |
| Dec 28, 2023 | 2.14B | 10.70% |
| Dec 29, 2022 | 1.93B | -53.41% |
| Dec 30, 2021 | 4.15B | 3.66% |
| Dec 30, 2020 | 4.00B | -9.75% |
| Sep 2, 2020 | 4.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 73.33B |
| Raia Drogasil | 25.47B |
| Hypera | 15.83B |
| Fleury | 7.79B |
| Odontoprev | 6.88B |
| Oncoclínicas do Brasil Serviços Médicos | 3.43B |
| Blau Farmacêutica | 2.20B |
| Diagnósticos da América | 1.86B |